RESUMO
Adjuvant effect of G2 (extraction of buffalo spleen) was assessed in intraperitoneally immunized rainbow trout (100-150â¯g) with killed- Y. ruckeri bacterin biotype I [0.1â¯mL (1â¯×â¯107â¯cells/fish) of vaccine diluted with the adjuvant in a ratio of 1:1 (V/V)] at 12.4⯱â¯1.3⯰C for 10 weeks. Leukocyte and lymphocyte counts, anti-Y. ruckeri antibody titer and relative percent survival (RPS) in fish vaccinated with vaccine containing the adjuvant were significantly higher than the immunized fish with Y. ruckeri antigen alone throughout the experiment (Pâ¯<â¯0.05), but neutrophils count and lysozyme activity were mostly significantly higher in the latter group (Pâ¯<â¯0.05). No difference was seen in the complement activity between vaccinated fish containing the adjuvant and vaccine alone (Pâ¯>â¯0.05). The results of this work for the first time demonstrated that inclusion of G2 as an adjuvant in Y. urckeri vaccine can improve the efficacy of the vaccine against Yersinia septicemia in rainbow trout.
Assuntos
Adjuvantes Imunológicos/administração & dosagem , Doenças dos Peixes/tratamento farmacológico , Oncorhynchus mykiss , Sepse/veterinária , Yersiniose/veterinária , Yersinia ruckeri/fisiologia , Animais , Búfalos , Doenças dos Peixes/microbiologia , Imunização/veterinária , Distribuição Aleatória , Sepse/tratamento farmacológico , Sepse/microbiologia , Baço/química , Vacinação/veterinária , Yersiniose/tratamento farmacológico , Yersiniose/microbiologiaRESUMO
IPNV in Atlantic salmon is represented by various strains with different virulence and immunogenicity linked to various motifs of the VP2 capsid. IPNV variant with P217, T221, A247 (PTA) motif is found to be avirulent in Atlantic salmon, but virulent in rainbow trout, and other salmonid species. This study describes a DNA vaccine delivered intramuscularly encoding the VP2 protein of infectious pancreatic necrosis virus (IPNV) with PTA motif that confers high protection in rainbow trout (Oncorhynchus mykiss). Intramuscular injection of 2, 5 and 10⯵g of DNA (pcDNA3.1-VP2) in rainbow trout fry (4-5â¯g), confers relative protection of 75-83% in the different vaccine groups at 30â¯days post vaccination (450° days). The VP2 gene is expressed in spleen, kidney, muscle and liver at day 30 post-vaccination (RT-PCR), and IFN-1 and Mx-1 mRNA are upregulated at early time post vaccination, and so also for IgM, IgT, CD4 and CD8 in the head kidney of vaccinated fish compared to controls, 15 and 30â¯days post vaccination. Significant increase of serum anti-IPNV antibodies was found 30-90â¯days post-vaccination that was correlated with protection levels. Mortality corresponded with viral VP4 gene expression were significantly decreased in vaccinated and challenged fish. This shows for the first time that a VP2-encoding DNA vaccine delivered intramuscularly elicits a high level of protection alongside with high levels of circulating antibodies in rainbow trout and a lowered viral replication.